LANDSCAPE
LIVE

Serial Number

79340665

Owner

Angle Europe Limited

Attorney

Christina M. Licursi

Filing Date

Jan 6, 2022

Add to watchlist:

No watchlists yet
View on USPTO

LANDSCAPE Trademark

Serial Number: 79340665 • Registration: 7423686

LANDSCAPE is a trademark filed by Angle Europe Limited on January 6, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Angle Europe Limited

10 Nugent Road,

Entity Type: 99

Trademark Details

Filing Date

January 6, 2022

Registration Date

June 25, 2024

Published for Opposition

April 9, 2024

Goods & Services

Medical apparatus, equipment and instruments for laboratory analysis and clinical diagnosis of human diseases, namely, medical diagnostic apparatus for testing DNA and RNA samples and medical diagnostic testing instruments for processing and analysis of genetic samples using gene expression tests, gene expression profiling assays and protein biomarkers; medical testing apparatus, equipment and instruments for testing body fluids, blood and plasma, cancer cells, and foetal cells; parts and fittings for the aforesaid goods, namely, diagnostic apparatus, equipment and instruments for cytology, histology and for use in detecting cancer

Diagnostic preparations and reagents for scientific or research use; Chemical reagents for non-medical purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry, science and medical research; buffer solutions and reagents for use with laboratory apparatus, namely, buffer solutions and reagents for scientific and research use for use with separation apparatus and analysis apparatus; diagnostic biomarkers, namely, nucleic acids, proteins and other biochemical ligands all of the foregoing being diagnostic preparations for scientific or research use; diagnostic kits comprised of diagnostic reagents and assay components for scientific and clinical research

Diagnostic medical reagents and assay components for testing of body fluids, including blood and plasma, and cells; diagnostic kits comprised of diagnostic reagents and assay components for clinical and medical use; all the foregoing not including any such goods that are prescription only pharmaceuticals, but including such non-pharmaceutical goods that are for companion diagnostics

Apparatus, equipment and instruments for cytology, histology and for use in detecting cancerous conditions not for medical use, but all for laboratory use, diagnostic or general research use in the fields of cytology and histology, namely, specimen collection and handling vials, pipettes, burettes, dispensing bottles for laboratory reagents, microplates and assay plates in the nature of test tubes, sample test tubes; Apparatus, equipment and instruments for cytology, histology and for use in detecting cancerous conditions not for medical use, but all for laboratory use, diagnostic or general research use in the fields of cytology and histology, namely, DNA analysis apparatus for laboratory use, apparatus for analysing genes for laboratory use; laboratory apparatus in the nature of cassettes for harvesting rare cells for use in laboratory, diagnostic or general research use; cell analyzer in the nature of flow cytometers and flow-based analyzers providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes therefor; apparatus for use in testing and analysing blood not for medical use, and all for laboratory use, diagnostic or general research use, namely, sample test tubes, vials, disposable dispenser syringes, pipettes, dispensing bottles for laboratory reagents, microplates and assay plates in the nature of test tubes; parts and fittings for the aforesaid goods, namely medical laboratory research instruments for use in the detection of cancer

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 29, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 28, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 7, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 7, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 25, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 25, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Apr 8, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 20, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 20, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 29, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 30, 2024 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 12, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 25, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 25, 2023 OPNR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Aug 4, 2023 GNS1
SUBSEQUENT FINAL EMAILED
Aug 4, 2023 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Aug 4, 2023 CFRC
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 1, 2023 GNFN
FINAL REFUSAL E-MAILED
Aug 1, 2023 GNFR
FINAL REFUSAL WRITTEN
Aug 1, 2023 CNFR
ASSIGNED TO EXAMINER
Jul 3, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2023 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 27, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 27, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 27, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 27, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 27, 2023 COAR
REFUSAL PROCESSED BY IB
Jan 15, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 26, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 26, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 5, 2022 RFCR
NON-FINAL ACTION WRITTEN
Oct 4, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
May 24, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 19, 2022 REPR